indocyanine green has been researched along with Wet Macular Degeneration in 110 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 89 (80.91) | 24.3611 |
| 2020's | 21 (19.09) | 2.80 |
| Authors | Studies |
|---|---|
| Amador, M; Bartsch, DU; Cavichini, M; Cheng, L; Chhablani, J; Dans, K; Freeman, WR; Jhingan, M | 1 |
| Cennamo, G; Clemente, L; Costagliola, C; Fossataro, F; Montorio, D | 1 |
| Cabral, D; Coscas, F; Coscas, G; Pinna, A; Serra, R | 1 |
| Jitpukdee, P; Thamphithak, R; Wongchaisuwat, N; Wongchaisuwat, P | 1 |
| Cheung, CMG; Teo, KYC; Wong, MYZ | 1 |
| deCarlo, TE; Kaneko, KN; Kokame, GT; Lian, R; Omizo, JN | 1 |
| Kim, DG; Kim, ES; Kim, JM; Kim, K; Yu, SY | 1 |
| Freund, KB; Leong, BCS; Sadda, SR; Sarraf, D; Teke, MY; Yu, HG; Yzer, S; Zatreanu, L | 1 |
| Kaneko, KN; Kokame, GT; Kokame, KA; Liu, K; Omizo, JN | 1 |
| Chung, H; Kim, HC; Kim, MA; Lee, H; Lee, M | 1 |
| Arikan, M; Eibenberger, K; Mittermüller, TJ; Orsolya, A; Pollreisz, A; Reiter, GS; Sacu, S; Schlanitz, FG; Schmidt-Erfurth, U; Told, R | 1 |
| Choi, M; Kim, SW; Oh, J; Yun, C | 1 |
| Deak, G; Gerendas, BS; Haj Najeeb, B; Schmidt-Erfurth, U | 1 |
| Aragona, E; Arrigo, A; Bandello, F; Battaglia Parodi, M; Battista, M; Di Nunzio, C; Romano, F | 1 |
| Arf, S; Ersoz, MG; Hocaoglu, M; Karacorlu, M; Sayman Muslubas, I | 1 |
| Bandello, F; Battista, M; Borrelli, E; Capuano, V; Corbelli, E; Miere, A; Querques, G; Querques, L; Sacconi, R; Souied, EH | 1 |
| Baek, J; Lee, A; Ra, H | 1 |
| Boon, CJF; Chung, WH; Dijkman, G; Mohabati, D; van Dijk, EHC; Veselinovic, S | 1 |
| Chakravarthy, U; Chen, SJ; Chhablani, J; Chong Teo, KY; Corvi, F; Gemmy Cheung, CM; Gomi, F; Gupta, V; Invernizzi, A; Kim, JE; Koh, AH; Kokame, G; Lai, TYY; Lee, WK; Mitchell, P; Ogura, Y; Ruamviboonsuk, P; Sadda, SR; Staurenghi, G; Tan, C; Wong, TY | 1 |
| Kokame, GT; Kokame, KA; Omizo, JN; Yamane, ML | 1 |
| Kim, CG; Kim, JH; Kim, JW; Lee, DW | 1 |
| Alovisi, C; Ciardella, A; Eandi, CM; Grossi, M; Missiroli, F; Morara, MC; Parravano, M; Ricci, F; Veronese, C; Virgili, G | 1 |
| Georgalas, I; Kanakis, M; Karatzenis, D; Lakoumentas, J; Malamos, P; Mylonas, G; Oikonomopoulos, N; Tsolkas, G | 1 |
| Agarwal, A; Di Nicola, M; Franzetti, F; Invernizzi, A; Staurenghi, G; Viola, F | 1 |
| Baratsits, M; Eibenberger, K; Hecht, A; Kroh, ME; Pollreisz, A; Rezar-Dreindl, S; Sacu, S; Schlanitz, FG; Schmidt-Erfurth, U; Told, R; Weigert, G | 1 |
| Byeon, SH; Kang, H; Kim, M; Kim, SS; Koh, HJ; Lee, SC | 1 |
| Chan, CM; Cheung, CMG; Lee, SY; Mathur, R; Mohla, A; Wong, TY; Yanagi, Y; Yeo, I | 1 |
| Aragona, E; Arrigo, A; Bandello, F; Capone, L; Parodi, MB; Pierro, L; Romano, F | 1 |
| Chen, KG; Chew, EY; Christakis, PG | 1 |
| Calvo-Gonzalez, C; Donate-López, J; Fernández-Pérez, C; Fernández-Vigo, JI; Reche-Frutos, J; Serrano-García, I | 1 |
| Blanco, R; Forte, R; Massamba, N; Querques, G; Querques, L; Souied, EH | 1 |
| Fujimura, S; Obata, R; Smith, RT; Takahashi, H; Ueta, T; Yanagi, Y | 1 |
| Chan, CC; Chew, E; Dalal, M; Ferris, F; Jacobs-El, N; Meyerle, C; Nicholson, B; Nussenblatt, R; Tuo, J | 1 |
| Chan, RV; Coleman, DJ; Khanifar, AA; Lloyd, HO; Rondeau, MJ; Silverman, RH | 1 |
| Huang, J; Jampol, LM; Lyon, AT; Mirza, RG; Punjabi, OS; Rodriguez, L | 1 |
| Chung, H; Kim, SJ; Lee, JE; McCarthy, LC; Newcombe, PJ; Park, UC; Shin, ES; Shin, JY; Xu, CF; Yu, HG | 1 |
| Bandello, F; Iacono, P; Introini, U; La Spina, C; Parodi, MB; Varano, M | 1 |
| Dröge, K; Fauser, S; Hermann, MM; Kirchhof, B; Muether, PS | 1 |
| Brar, M; Kopsachilis, N; Mathew, R; Pefkianaki, M; Richardson, M; Sivaprasad, S | 1 |
| Aragon, AV; Rush, RB; Simunovic, MP; Vandiver, L; Ysasaga, JE | 1 |
| Ellabban, AA; Miyake, M; Nakata, I; Ogino, K; Oishi, A; Ooto, S; Takahashi, A; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
| Chang, YS; Cho, HJ; Kim, CG; Kim, JH; Kim, JW; Yoo, SJ | 1 |
| Cohen, SY; Delcourt, C; Korobelnik, JF; Le Goff, M; Puche, N; Querques, G; Sahel, J; Souied, EH; Zerbib, J | 1 |
| den Hollander, AI; Fauser, S; Grefkes, C; Hermann, MM; Hoyng, CB; Kirchhof, B; Lichtner, P; Muether, PS; Smailhodzic, D; van Asten, F | 1 |
| Kinoshita, S; Koizumi, H; Yamagishi, T; Yamazaki, T | 1 |
| Kishi, S; Mukai, R; Sato, T | 1 |
| Kang, HM; Kwon, HJ; Lee, CS; Lee, SC; Yi, JH | 1 |
| Ellabban, AA; Oishi, A; Ooto, S; Takahashi, A; Tamura, H; Tsujikawa, A; Ueda-Arakawa, N; Yamashiro, K; Yoshimura, N | 1 |
| Hautamäki, A; Immonen, I; Järvelä, I; Kivioja, J; Liinamaa, MJ; Luoma, A; Savolainen, ER; Seitsonen, S | 1 |
| Iijima, H; Imasawa, M; Kubota, T; Mabuchi, F; Sakurada, Y; Sugiyama, A; Yoneyama, S | 1 |
| Cho, SW; Han, JI; Kim, CG; Kim, JH; Kim, JW; Lee, TG | 1 |
| Freund, KB; Mrejen, S; Shah, SA; Shah, VP | 1 |
| Chang, YS; Kim, CG; Kim, JH; Kim, JW; Lee, TG | 1 |
| Bacherini, D; Biagini, I; Finocchio, L; Giacomelli, G; Giansanti, F; Menchini, U; Virgili, G | 1 |
| Coco, RM; Sala-Puigdollers, A | 1 |
| Kawasaki, R; Koto, T; Ozawa, Y; Sasaki, M; Shinoda, H; Tsubota, K; Uchida, A; Wong, TY | 1 |
| Agrón, E; Chew, E; Cukras, C; Cunningham, D; Ferris, F; Jacobs-El, N; Meyerle, CB; Nicholson, BP; Nigam, D; Stetson, PF; Toy, B; Wiley, H; Wong, W | 1 |
| Cho, HJ; Han, JI; Kim, HS; Kim, JH; Kim, JW; Koh, KM; Lee, TG; Lew, YJ | 1 |
| Kim, BH; Park, KH; Park, SJ; Woo, SJ | 1 |
| Amoaku, W; Azuara-Blanco, A; Burr, JM; Castillo, MM; Elders, A; Fraser, C; Lois, N; Lotery, AJ; Mowatt, G; Ramsay, CR | 1 |
| Kurihara, T; Nagai, N; Okamoto, T; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
| Abraham, P; Chan, CK; Lin, SG; McCannel, CA; Nuthi, AS; Sarraf, D | 1 |
| Gotoh, T; Iijima, H; Kubota, T; Mabuchi, F; Nakamura, Y; Sakurada, Y; Sugiyama, A; Tateno, Y; Yoneyama, S | 1 |
| Iida, T; Kano, M; Kawasaki, R; Koizumi, H; Maruko, I; Okada, AA; Saito, M; Sekiryu, T; Yamamoto, A | 1 |
| Kim, HW; Lee, JE; Lee, SJ | 1 |
| Freund, KB; Querques, G; Souied, EH | 1 |
| Iida, T; Maruko, I; Oyamada, H; Saito, M; Sekiryu, T; Sugano, Y | 1 |
| Ameri, H; Bhavsar, KV; Freund, KB; Jung, JJ; Nagiel, A; Querques, G; Sadda, SR; Sarraf, D; Spaide, RF | 1 |
| Gomi, F; Iwata, E; Kano, M; Maruko, R; Mori, R; Oshima, Y; Saito, M; Yamashita, A | 1 |
| Byeon, SH; Kim, H; Kim, M; Kim, SM; Kim, SS; Koh, HJ; Lee, CS; Lee, JH; Lee, SC | 1 |
| Bertazzi, L; Guerriero, M; Pertile, G; Polito, A; van Romunde, SH | 1 |
| Chang, YS; Kim, J; Kim, JH; Lew, YJ; Yoo, SJ | 1 |
| Nomura, Y; Yanagi, Y | 1 |
| Benjelloun, F; Coscas, F; Coscas, G; Dirani, A; Lupidi, M; Semoun, O; Souied, EH; Zerbib, J | 1 |
| Chung, H; Ji, B; Kim, HC; Lee, H | 1 |
| Cagini, C; Coscas, F; Coscas, G; Français, C; Lupidi, M; Souied, EH | 1 |
| Capuano, V; El Ameen, A; Miere, A; Querques, G; Semoun, O; Souied, EH | 1 |
| An, L; Chen, CL; Durbin, MK; Gregori, G; Miller, A; Robbins, G; Roisman, L; Rosenfeld, PJ; Stetson, PF; Wang, RK; Zhang, A; Zhang, Q; Zheng, F | 1 |
| Bandello, F; Casalino, G; Chakravarthy, U; Upendran, M | 1 |
| Bonyadi, M; Jabbarpoor Bonyadi, MH; Moein, H; Mohammadian, T; Soheilian, M; Yaseri, M | 1 |
| Cho, HJ; Cho, SW; Han, JI; Kim, HS; Kim, JW; Lee, TG; Lew, YJ; Yoo, SG | 1 |
| Alagoz, C; Alkin, Z; Garip, R; Ozkaya, A; Perente, I; Taskapili, M; Yazici, AT | 1 |
| Cho, JH; Cho, KH; Park, KH; Park, SJ; Ryoo, NK; Woo, SJ | 1 |
| Chang, YS; Kim, HS; Kim, JH; Kim, JW; Lee, TG | 1 |
| Bird, AC; Blodi, BA; Bottoni, F; Chakravarthy, U; Chew, EY; Csaky, K; Curcio, CA; Danis, R; Fleckenstein, M; Freund, KB; Grunwald, J; Guymer, R; Holz, FG; Hoyng, CB; Jaffe, GJ; Liakopoulos, S; Lindner, M; Monés, JM; Oishi, A; Pauleikhoff, D; Rosenfeld, PJ; Sadda, SR; Sarraf, D; Schmitz-Valckenberg, S; Spaide, RF; Staurenghi, G; Tadayoni, R; Tufail, A; Wolf, S | 1 |
| Frennesson, C; Nilsson, SE; Nilsson, UL; Peebo, BB | 1 |
| Chung, H; Kim, JG; Lee, JY; Lee, SY; Lim, JY; Yoon, YH | 1 |
| Caramoy, A; Kirchhof, B; Liakopoulos, S | 1 |
| Batar, B; Dinç, UA; Görgün, E; Güven, GS; Güven, M; Küçümen, B; Ulus, T; Ünal, M; Yenerel, M; Yüksel, A | 1 |
| Georgalas, I; Kotsolis, AI; Ladas, ID; Papakonstantinou, D; Rouvas, AA; Vergados, I | 1 |
| Ali, M; Bansal, S; Baxter, PD; Cassidy, F; Inglehearn, CF; McKibbin, M; West, K; Williams, G | 1 |
| Deak, G; Kiss, C; Munk, M; Sacu, S; Schmidt-Erfurth, U; Sulzbacher, F | 1 |
| Bernardes, R; Cachulo, ML; Faria de Abreu, JR; Fonseca, P; Nunes, S; Silva, R; Vilhena, N | 1 |
| Ham, DI; Lee, MY; Yoon, J | 1 |
| Mendonça, LS; Saito, M; Spaide, RF; Switzer, DW; Zweifel, SA | 1 |
| Harbo Bundsgaard, K; Ilginis, T; Ottosen, S; Uggerhøj Andersen, C; Vorum, H | 1 |
| Iida, T; Kano, M; Saito, M | 2 |
| Akagi-Kurashige, Y; Miyake, M; Nakata, I; Ooto, S; Tamura, H; Tomita, K; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
| Alemany-Rubio, E; Fregona, I; Midena, E; Pilotto, E; Segalina, S; Sportiello, P; Vujosevic, S | 1 |
| Bhargava, M; Cheung, CM; Mathur, R; Mun, CC; Wong, D; Wong, TY; Xiang, L | 1 |
| Gomi, F; Ishikawa, K; Iwata, E; Nishida, K; Sawa, M; Terasaki, H | 1 |
| Hu, Y; Li, X; Sun, X; Zhang, J; Zhang, M | 1 |
| Freund, KB; Fung, AT; Yannuzzi, LA | 1 |
| Goto, H; Kemma, H; Nagaoka, T; Nakamura, A; Sota, T; Yamauchi, Y | 1 |
| Fujiwara, A; Nitta, E; Shiraga, F; Shiragami, C; Shirakata, Y; Yamashita, A | 1 |
| Hautamäki, A; Immonen, I; Oikkonen, J; Onkamo, P | 1 |
| Mathew, R; Richardson, M; Sivaprasad, S | 1 |
| Ha, HS; Kang, SW; Kim, JH; Kim, JR; Kim, SJ | 1 |
| Baek, JS; Cho, HJ; Cho, SW; Kim, CG; Kim, JW | 1 |
1 review(s) available for indocyanine green and Wet Macular Degeneration
| Article | Year |
|---|---|
Optical coherence tomography for the diagnosis of neovascular age-related macular degeneration: a systematic review.
Topics: Coloring Agents; Diagnostic Techniques, Ophthalmological; Fluorescein Angiography; Humans; Indocyanine Green; Sensitivity and Specificity; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2014 |
6 trial(s) available for indocyanine green and Wet Macular Degeneration
| Article | Year |
|---|---|
THE RAP STUDY, REPORT TWO: The Regional Distribution of Macular Neovascularization Type 3, a Novel Insight Into Its Etiology.
Topics: Adult; Angiogenesis Inhibitors; Arteriovenous Fistula; Choroid; Choroidal Neovascularization; Coloring Agents; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Multimodal Imaging; Prospective Studies; Retinal Neovascularization; Retinal Vessels; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2020 |
Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Benzopyrans; Coloring Agents; Conjunctiva; Enzyme Inhibitors; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; TOR Serine-Threonine Kinases; Treatment Outcome; Visual Acuity; Wet Macular Degeneration | 2013 |
Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Contrast Sensitivity; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Prospective Studies; Ranibizumab; Retinal Detachment; Retinal Neovascularization; Retinal Pigment Epithelium; Risk Assessment; Sickness Impact Profile; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Prospective Studies; Ranibizumab; Retreatment; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity; Wet Macular Degeneration | 2012 |
Bevacizumab for neovascular age-related macular degeneration in China.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; China; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Retina; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
103 other study(ies) available for indocyanine green and Wet Macular Degeneration
| Article | Year |
|---|---|
CHOROIDAL IMAGING BIOMARKERS TO PREDICT HIGHLY RESPONSIVE AND RESISTANT CASES TREATED WITH STANDARDIZED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR REGIMEN IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Biomarkers; Choroid; Choroidal Neovascularization; Coloring Agents; Drug Resistance; Female; Fluorescein Angiography; Follow-Up Studies; Geographic Atrophy; Humans; Indocyanine Green; Intravitreal Injections; Male; Multimodal Imaging; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Drusen; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
Dark halo, a new biomarker in macular neovascularization: comparison between OCT angiography and ICGA-a pilot prospective study.
Topics: Angiogenesis Inhibitors; Biomarkers; Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Prospective Studies; Reproducibility of Results; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2022 |
POLYPOIDAL CHOROIDAL NEOVASCULARIZATION VERSUS TYPE 1 CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: A Fractal Analysis Study.
Topics: Choroidal Neovascularization; Fluorescein Angiography; Fractals; Humans; Indocyanine Green; Macular Degeneration; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2022 |
Application of Deep Learning for Automated Detection of Polypoidal Choroidal Vasculopathy in Spectral Domain Optical Coherence Tomography.
Topics: Choroid; Deep Learning; Fundus Oculi; Humans; Indocyanine Green; Tomography, Optical Coherence; Wet Macular Degeneration | 2022 |
CHOROIDAL VASCULAR ALTERATIONS IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Choroid; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2023 |
Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Drug Resistance; Ethnicity; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ophthalmoscopy; Polyps; Prevalence; Retrospective Studies; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2019 |
Five-Year Follow-Up of Unaffected Fellow Eyes in Patients with Polypoidal Choroidal Vasculopathy.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Incidence; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2020 |
SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Diagnostic Errors; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Multimodal Imaging; Optical Imaging; Retinal Detachment; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitelliform Macular Dystrophy; Wet Macular Degeneration; Young Adult | 2020 |
Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration; White People | 2020 |
ASSOCIATION OF TREATMENT RESPONSE WITH QUANTITATIVE CHANGES IN CHOROIDAL NEOVASCULARIZATION AND CHOROIDAL VESSEL IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2020 |
SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY, FLUORESCEIN ANGIOGRAPHY, AND INDOCYANINE GREEN ANGIOGRAPHY COMPARISONS REVISITED: Using a Novel Deep-Learning-Assisted Approach for Image Registration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Deep Learning; Diagnosis, Computer-Assisted; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2020 |
OCT Angiography Features of Neovascularization as Predictive Factors for Frequent Recurrence in Age-Related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Predictive Value of Tests; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2020 |
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CAN CATEGORIZE DIFFERENT SUBGROUPS OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Ciliary Arteries; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Multimodal Imaging; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2020 |
Features of neovascularization in pachychoroid neovasculopathy compared with type 1 neovascular age-related macular degeneration on optical coherence tomography angiography.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Ciliary Arteries; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2020 |
OCT-A characterisation of recurrent type 3 macular neovascularisation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Multimodal Imaging; Recurrence; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
Choroidal vascular densities of macular disease on ultra-widefield indocyanine green angiography.
Topics: Adult; Aged; Aged, 80 and over; Choroid; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Retinal Vessels; Tomography, Optical Coherence; Wet Macular Degeneration; Young Adult | 2020 |
The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Polyps; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Asia; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Female; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ophthalmology; Pacific States; Photochemotherapy; Photography; Polyps; Sensitivity and Specificity; Societies, Medical; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2021 |
Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2021 |
LONG-TERM COURSE AND VISUAL OUTCOMES OF PRECHOROIDAL CLEFT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Angiogenesis Inhibitors; Bruch Membrane; Choroid; Choroidal Neovascularization; Coloring Agents; Extracellular Space; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retinal Pigment Epithelium; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
Indocyanine Green Angiography and Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Computed Tomography Angiography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2017 |
OCT-Angiography for monitoring and managing neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Prospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2017 |
Choroidal neovascular membranes secondary to intraocular tuberculosis misdiagnosed as neovascular age-related macular degeneration.
Topics: Aged; Choroidal Neovascularization; Diagnostic Errors; Female; Fluorescein Angiography; Humans; Indocyanine Green; Interferon-gamma Release Tests; Male; Middle Aged; Multimodal Imaging; Photography; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Tuberculin Test; Tuberculosis, Ocular; Wet Macular Degeneration | 2018 |
Comparison of SD-Optical Coherence Tomography Angiography and Indocyanine Green Angiography in Type 1 and 2 Neovascular Age-related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2018 |
COMBINING EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY AND BLOOD FLOW ANALYSIS FOR DETECTING CHOROIDAL NEOVASCULAR COMPLEXES IN PIGMENT EPITHELIAL DETACHMENTS.
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Male; Middle Aged; Regional Blood Flow; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2019 |
Incidence of Fellow Eye Involvement in Patients With Unilateral Exudative Age-Related Macular Degeneration.
Topics: Aged; Choroidal Neovascularization; Cohort Studies; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Incidence; Indocyanine Green; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2018 |
Advanced Optical Coherence Tomography Angiography Analysis of Age-related Macular Degeneration Complicated by Onset of Unilateral Choroidal Neovascularization.
Topics: Aged; Case-Control Studies; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Microscopy, Acoustic; Middle Aged; Prospective Studies; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2018 |
10-YEAR FOLLOW-UP OF A SUBCLINICAL CHOROIDAL NEOVASCULAR MEMBRANE IN A PATIENT WITH AGE-RELATED MACULAR DEGENERATION.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Multimodal Imaging; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept.
Topics: Aged; Angiogenesis Inhibitors; Coloring Agents; Drug Substitution; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Intravitreal Injections; Macula Lutea; Male; Prospective Studies; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2019 |
Precursors of type 3 neovascularization: a multimodal imaging analysis.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Early Diagnosis; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Multimodal Imaging; Ophthalmoscopy; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2013 |
Characteristics of fundus autofluorescence and drusen in the fellow eyes of Japanese patients with exudative age-related macular degeneration.
Topics: Aged; Asian People; Choroidal Neovascularization; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Japan; Male; Observer Variation; Polyps; Retinal Drusen; Wet Macular Degeneration | 2013 |
Age-related macular degeneration: choroidal ischaemia?
Topics: Choroid; Coloring Agents; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Ischemia; Prospective Studies; ROC Curve; Tomography, Optical Coherence; Ultrasonography; Wet Macular Degeneration | 2013 |
Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Ranibizumab; Retinal Detachment; Retinal Diseases; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |
Genetic factors associated with response to intravitreal ranibizumab in Korean patients with neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Asian People; Coloring Agents; Eye Proteins; Female; Fluorescein Angiography; Genetic Markers; Genotype; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prospective Studies; Ranibizumab; Republic of Korea; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Wet Macular Degeneration | 2014 |
Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Prospective Studies; Ranibizumab; Retinal Hemorrhage; Retreatment; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2014 |
Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Ranibizumab; Time Factors; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |
Correlation of fundus fluorescein angiography and spectral-domain optical coherence tomography in identification of membrane subtypes in neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Female; Fluorescein Angiography; Fluorescent Dyes; Humans; Indocyanine Green; Male; Ranibizumab; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2014 |
Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.
Topics: Age Factors; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Retina; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Detachment; Wet Macular Degeneration | 2014 |
Multimodal evaluation of macular function in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Coloring Agents; Electroretinography; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Male; Multimodal Imaging; Prospective Studies; Retina; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Visual Fields; Wet Macular Degeneration | 2014 |
Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Retinal Hemorrhage; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2014 |
Risk factors for exudative age-related macular degeneration in a large French case-control study.
Topics: Aged; Case-Control Studies; Coloring Agents; Complement Factor H; Fatty Acids, Omega-3; Female; Fluorescein Angiography; France; Fruit; Genotyping Techniques; Humans; Indocyanine Green; Male; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proteins; Risk Factors; Smoking; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Female; Fluorescein Angiography; Genotype; Genotyping Techniques; Humans; Indocyanine Green; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Visual Acuity; Wet Macular Degeneration | 2014 |
Subfoveal choroidal thickness in retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Male; Organ Size; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
Precursor stage of retinal pigment epithelial tear in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Photochemotherapy; Ranibizumab; Retinal Perforations; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2014 |
Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Organ Size; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity; Wet Macular Degeneration | 2014 |
Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography.
Topics: Aged; Aged, 80 and over; Axial Length, Eye; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Imaging, Three-Dimensional; Indocyanine Green; Macula Lutea; Male; Prospective Studies; Retinal Drusen; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2014 |
The IL-8, VEGF, and CFH polymorphisms and bevacizumab in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Genotype; Humans; Indocyanine Green; Interleukin-8; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2014 |
Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Genotype; Humans; Indocyanine Green; Male; Microscopy, Confocal; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proteins; Retinal Drusen; Retinal Neovascularization; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
Small retinal haemorrhages accompanied by macular soft drusen: prevalence, and funduscopic and angiographic characteristics.
Topics: Aged; Aged, 80 and over; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Predictive Value of Tests; Prevalence; Republic of Korea; Retinal Drusen; Retinal Hemorrhage; Retinal Neovascularization; Sex Distribution; Wet Macular Degeneration | 2014 |
Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Photography; Ranibizumab; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Phacoemulsification; Ranibizumab; Recurrence; Retrospective Studies; Risk Factors; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2014 |
Results of intravitreal ranibizumab with a prn regimen in the treatment of extrafoveal and juxtafoveal neovascular membranes in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2014 |
Management of significant reactivation of old disciform scars in wet age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Cicatrix; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Laser Coagulation; Male; Time Factors; Visual Acuity; Wet Macular Degeneration | 2014 |
Early signs of exudative age-related macular degeneration in Asians.
Topics: Aged; Asian People; Coloring Agents; Early Diagnosis; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Drusen; Retinal Pigment Epithelium; Retrospective Studies; Risk Factors; Visual Acuity; Wet Macular Degeneration | 2014 |
Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Observer Variation; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Combined Modality Therapy; Endotamponade; Female; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
Topics: Aged; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.
Topics: Aged; Aptamers, Nucleotide; Basement Membrane; Coloring Agents; Epiretinal Membrane; Fluorescein Angiography; Humans; Indocyanine Green; Intraoperative Period; Male; Retinal Perforations; Vascular Endothelial Growth Factor A; Vitrectomy; Wet Macular Degeneration | 2014 |
Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Choroidal Neovascularization; Coloring Agents; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Luminescent Measurements; Male; Polyps; Ranibizumab; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Organ Size; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
How has high-resolution multimodal imaging refined our understanding of the vasogenic process in type 3 neovascularization?
Topics: Coloring Agents; Diagnostic Techniques, Ophthalmological; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Retinal Neovascularization; Tomography, Optical Coherence; Wet Macular Degeneration | 2015 |
Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Male; Photochemotherapy; Ranibizumab; Retina; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Papilledema; Retinal Detachment; Retinal Neovascularization; Retinal Pigment Epithelium; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.
Topics: Aged; Aged, 80 and over; Aneurysm; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Polyps; Retinal Hemorrhage; Retinal Perforations; Retinal Vessels; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2015 |
Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration.
Topics: Aged, 80 and over; Autografts; Blindness; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Indocyanine Green; Macula Lutea; Male; Multimodal Imaging; Postoperative Complications; Retrospective Studies; Silicone Oils; Tomography, Optical Coherence; Treatment Outcome; Vision, Low; Visual Acuity; Wet Macular Degeneration | 2015 |
Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population.
Topics: Aged; Angiogenesis Inhibitors; Asian People; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Incidence; Indocyanine Green; Male; Republic of Korea; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2016 |
Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Capillary Permeability; Choroid; Drug Resistance; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retrospective Studies; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Ophthalmoscopy; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2015 |
CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Drug Combinations; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Polyps; Ranibizumab; Retina; Retrospective Studies; ROC Curve; Statistics as Topic; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy.
Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EARLY TYPE 3 NEOVASCULARIZATION.
Topics: Aged; Aged, 80 and over; Arterio-Arterial Fistula; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Prospective Studies; Retinal Artery; Retinal Neovascularization; Retinal Pigment Epithelium; Tomography, Optical Coherence; Wet Macular Degeneration | 2015 |
Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Prospective Studies; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2016 |
Stellate nonhereditary idiopathic foveomacular retinoschisis concomitant to exudative maculopathies.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Retinoschisis; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
Evaluation of C-reactive protein and CC-cytokine ligand 2 polymorphism interaction for age-related macular degeneration.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Chemokine CCL2; Coloring Agents; Female; Fluorescein Angiography; Gene Frequency; Humans; Indocyanine Green; Male; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Wet Macular Degeneration | 2016 |
RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Ranibizumab; Retinal Perforations; Retinal Pigment Epithelium; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retinal Detachment; Retrospective Studies; Vascular Endothelial Growth Factor A; Vitelliform Macular Dystrophy; Wet Macular Degeneration | 2016 |
Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Cohort Studies; Coloring Agents; Female; Fluorescein Angiography; Humans; Incidence; Indocyanine Green; Male; Polyps; Retinal Hemorrhage; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
DIAGNOSIS OF TYPE 3 NEOVASCULARIZATION BASED ON OPTICAL COHERENCE TOMOGRAPHY IMAGES.
Topics: Aged; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Observer Variation; Reproducibility of Results; Retinal Detachment; Retinal Neovascularization; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Wet Macular Degeneration | 2016 |
Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings.
Topics: Aged; Clinical Protocols; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Male; Multimodal Imaging; Optical Imaging; Photography; Retinal Pigment Epithelium; Tomography, Optical Coherence; Wet Macular Degeneration | 2017 |
Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Male; Patient Satisfaction; Prospective Studies; Quality of Life; Ranibizumab; Reading; Sickness Impact Profile; Tomography, Optical Coherence; Visual Acuity; Visual Fields; Vitreous Body; Wet Macular Degeneration | 2010 |
Recurrence of choroidal neovascular membrane after autologous transplantation of RPE and choroid for neovascular AMD.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Recurrence; Retinal Pigment Epithelium; Tomography, Optical Coherence; Transplantation, Autologous; Visual Acuity; Wet Macular Degeneration | 2011 |
Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorescein Angiography; Genotype; Geographic Atrophy; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Indocyanine Green; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Wet Macular Degeneration | 2011 |
Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Perforations; Retinal Pigment Epithelium; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2011 |
CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Complement Factor H; Female; Fluorescein Angiography; Genotype; High-Temperature Requirement A Serine Peptidase 1; Humans; Indocyanine Green; Intravitreal Injections; Male; Pilot Projects; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Ranibizumab; Serine Endopeptidases; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
Diagnostic evaluation of type 2 (classic) choroidal neovascularization: optical coherence tomography, indocyanine green angiography, and fluorescein angiography.
Topics: Blood-Retinal Barrier; Capillary Permeability; Choroidal Neovascularization; Coloring Agents; Diagnostic Techniques, Ophthalmological; Fluorescein Angiography; Humans; Indocyanine Green; Tomography, Optical Coherence; Wet Macular Degeneration | 2011 |
Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Topics: Aged; Aged, 80 and over; Capillary Permeability; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Retina; Retinal Drusen; Retinal Vessels; Risk Factors; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2011 |
Clinical characteristics of reticular pseudodrusen in Korean patients.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Korea; Male; Middle Aged; Ophthalmoscopy; Retinal Drusen; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2012 |
Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Glaucoma, Open-Angle; Humans; Indocyanine Green; Male; Middle Aged; Ophthalmoscopy; Optic Atrophy; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2012 |
Polypoidal choroidal vasculopathy in patients diagnosed with neovascular age-related macular degeneration in Denmark.
Topics: Aged; Aged, 80 and over; Choroid Diseases; Coloring Agents; Denmark; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Peripheral Vascular Diseases; Polyps; Prevalence; Visual Acuity; Wet Macular Degeneration | 2012 |
Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid Diseases; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Follow-Up Studies; Genotype; Humans; Indocyanine Green; Intravitreal Injections; Male; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Polyps; Proteins; Ranibizumab; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
Confocal scanning laser ophthalmoscope in the retromode imaging modality in exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Coloring Agents; Epiretinal Membrane; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Edema; Male; Middle Aged; Ophthalmoscopy; Retina; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2013 |
Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Photochemotherapy; Polyps; Prognosis; Prospective Studies; Retinal Hemorrhage; Time Factors; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2013 |
Comparison of different treatment intervals between bevacizumab injection and photodynamic therapy in combined therapy for age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity; Wet Macular Degeneration | 2012 |
Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration.
Topics: Aged; Central Serous Chorioretinopathy; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Neovascularization; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2012 |
Novel automated screening of age-related macular degeneration.
Topics: Aged; Area Under Curve; Coloring Agents; Diagnostic Techniques, Ophthalmological; Fluorescein Angiography; Humans; Indocyanine Green; Macula Lutea; Middle Aged; Ophthalmoscopy; ROC Curve; Spectroscopy, Near-Infrared; Wet Macular Degeneration | 2012 |
One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Intravitreal Injections; Male; Photochemotherapy; Recurrence; Retinal Neovascularization; Retreatment; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
Correlation between components of newly diagnosed exudative age-related macular degeneration lesion and focal retinal sensitivity.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Contrast Sensitivity; Cross-Sectional Studies; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Indocyanine Green; Male; Retina; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Visual Fields; Wet Macular Degeneration | 2014 |
Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |
Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Basement Membrane; Coloring Agents; False Positive Reactions; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Macula Lutea; Male; Observer Variation; Predictive Value of Tests; Prognosis; Ranibizumab; Reproducibility of Results; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Wet Macular Degeneration | 2013 |
Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Ranibizumab; Retinal Drusen; Retinal Neovascularization; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |
Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Lens, Crystalline; Male; Middle Aged; Pseudophakia; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |